COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.

White NJ.; Watson JA.; Hoglund RM.; Chan XHS.; Cheah PY.; Tarning J.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.

White NJ., Watson JA., Hoglund RM., Chan XHS., Cheah PY., Tarning J.

Nicholas White and coauthors discuss chloroquine and hydroxychloroquine pharmacology in the context of possible treatment of SARS-CoV-2 infection.

Original publication

DOI

10.1371/journal.pmed.1003252

Type

Journal article

Journal

PLoS Med

Publication Date

09/2020

Volume

Keywords

Antiviral Agents, Betacoronavirus, Chloroquine, Coronavirus Infections, Humans, Hydroxychloroquine, Pandemics, Pneumonia, Viral